Furthermore, there was no difference in the mean (SD) transferrin saturation between patients with MBD (24.4% [11.4%]) and healthy controls (25.4% [10.9%]; P = .429; Table 1, Supplementary Figure S2). This evidence concerns the gene TF and Marchiafava-Bignami disease.